SB-204741: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 28: | Line 28: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:SB-204,741 structure.png|SB-204741 | |||
</gallery> | |||
Latest revision as of 01:30, 20 February 2025
SB-204741 is a drug that acts as a selective antagonist for the serotonin receptor subtype 5-HT2B. It has been used in scientific research to investigate the function of this receptor, and has been found to have a variety of effects in animal studies, such as reducing appetite and having anti-inflammatory effects.
Pharmacology[edit]
SB-204741 is a selective antagonist for the 5-HT2B receptor, meaning it blocks the action of serotonin at this receptor. This can have a variety of effects, as the 5-HT2B receptor is involved in many different physiological processes.
Mechanism of action[edit]
SB-204741 works by binding to the 5-HT2B receptor and preventing serotonin from activating it. This can reduce the effects of serotonin in the body, which can have a variety of effects depending on the specific physiological process involved.
Uses in research[edit]
SB-204741 has been used in scientific research to investigate the function of the 5-HT2B receptor. It has been found to have a variety of effects in animal studies, such as reducing appetite and having anti-inflammatory effects.
Side effects[edit]
As with any drug, SB-204741 can have side effects. These can vary depending on the dose and individual response to the drug. Some potential side effects include nausea, vomiting, and dizziness.
